-+ 0.00%
-+ 0.00%
-+ 0.00%

Pentwater Capital cuts Faron Pharmaceuticals stake below 3% via cash-settled swap

PUBT·09/04/2026 10:04:42
Listen to the news
Pentwater Capital cuts Faron Pharmaceuticals stake below 3% via cash-settled swap
  • Pentwater Capital Management cut its exposure in Faron Pharmaceuticals below the 3% disclosure threshold via cash-settled swap instruments.
  • The move took effect on Sep. 1, 2026, down from a previously disclosed 3.88% held through financial instruments.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faron Pharmaceuticals Oyj published the original content used to generate this news brief on September 04, 2026, and is solely responsible for the information contained therein.